Cambridge Healthtech Institute’s 5th Annual

Adoptive T Cell Therapy 2: Development

August 30-31, 2018

In 2017, two CAR T cell therapies were approved by the Food and Drug Administration (FDA). With multiple engineered receptors making preclinical impact, many biotech and pharma companies are already entering other clinical trials in a race to get to market. Has this promising field finally reached a tipping point? Technical considerations and translational challenges relating to cell therapy development, manufacturing practicability, clinical trial approaches, cell quality and persistence, and patient management remain. Cambridge Healthtech Institute’s 5th Annual Adoptive T Cell Therapy 2: Development conference focuses on the steps needed to deliver CAR, TCR, and TIL therapies to the clinic. Overall, this event addresses clinical progress, case studies, and the critical components for making adoptive T cell therapy work.

Coverage will include, but is not limited to:

  • What’s New in Adoptive Cell Therapy
    • New developments: Leapfrogging to commercialization
    • New tools: Next-gen CAR designs, gene editing, off-the-shelf cells
    • Emerging targets: Tumor-specific mutations
  • Autologous Immune Cell Products
  • Adoptive Cell Therapy Using Non-Genetically Manipulated Lymphocytes
    • Improving and extending T cell therapies to target tumor-specific mutation
  • Adoptive Cell Therapy Using Chimeric Antigen Receptors (CAR) and T Cell Receptors (TCR)
    • Increasing T cell potency and persistence
    • Creating more controllable T cells
    • Moving towards treatment of solid malignancies
    • Clinical trial updates
  • Allogeneic Immune Cell Products
    • New platform technologies
    • Preclinical data and clinical studies

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is February 9, 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286